Career

An MSc Eng in Bioinformatics and Systems Biology opens up a range of job opportunities, but DTU graduates tend to gravitate towards the biotechnology and pharmaceutical industries, and university research.

Many of our MSc graduates choose to go on to do a PhD afterwards—either an ordinary PhD or an Industrial PhD in collaboration with a company. You can continue your studies at DTU or another Danish university, but many of our graduates do their PhDs abroad, and we have alumni at universities like Harvard.

Typical fields of work

Graduates with an MSc Eng in Bioinformatics and Systems Biology generally work with research and development at universities and hospitals, or in companies. Your competences will be in high demand in the analysis of the large volumes of data produced through biomedical analyses, and you will be able to take part in the development of medicines, vaccines, etc. Your knowledge within the field will also be useful in the consulting sector and in patent agencies.

Career opportunities

There are many opportunities, both in Denmark and abroad, for jobs in which your competences in bioinformatics and systems biology will be in high demand. Typical employers include:

  • The biotech industry, e.g. Novozymes A/S and Novo Nordisk A/S,
  • The pharmaceutical industry, e.g. LEO Pharma A/S and Lundbeck A/S
  • The research community at universities in Denmark and abroad

Pursue a PhD

Once you have an MSc in Engineering, you might get the opportunity to continue your studies and apply for admission to the three-year PhD, which at DTU is a research-based programme ranking among the best in the world. You can do either a regular PhD or an industrial PhD, the latter with concurrent employment in a company.

As a PhD student, you will be part of a research group and will carry out an independent scientific project.

Approx. 400 new PhD students are enrolled at the various departments at DTU every year. There are around 100 PhD students enrolled in DTU Systems Biology alone, and this number is set to increase in the years ahead.